United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for LadRx Corp? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 242.31% | - | -13.6% | -13.6% | -13.6% | -13.6% |
|---|---|---|---|---|---|---|
| ROA | -101.02% | -0.68% | -0.68% | -0.68% | -0.68% | -0.68% |
| Total Assets | $839.51K | $839.51K | $839.51K | $839.51K | $839.51K | $839.51K |
| Net Income | -$1,589.68K | -$5.71K | -$5.71K | -$5.71K | -$5.71K | -$5.71K |